Visualisation of significantly differentially expressed genes (DEGs). by Mohammed A. Alfattah (18271622)

Top 10 most significant DEGs. by Foluwasomi A. Oyefeso (15999113)

Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

The profile of the 263 significant differentially expressed metabolites (DEMs). by Haiying Yang (11707725)

Subjects:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

FTA card stabilization of YFV RNA decrease at high temperature. by Emily H. Davis (12878086)

Database of the significantly enriched gene ontology terms of the DEGs. by Camilo Escobar-Sierra (18150360)

Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance). by Christina Gress (11536883)

“…<p>Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”

Sampling point (Source: by Yonggang Huang (223155)

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Late onset DEG (identified at later timepoints) from significant pathways. by Sung-Hyun Park (196247)

DEG KEGG pathway. by Xinzhuan Yao (10095316)

After moderate and severe TBI, PWI revealed CBF was significantly decreased in the ipsilateral cortex and hippocampus at several time points relative to sham animals. by Juliana Sanchez-Molano (16792787)

Summary of top five significant pathways enriched by the 345 late onset DEG. by Sung-Hyun Park (196247)

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. by Liwen Wang (276995)

Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP₂ antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance). by Christina Gress (11536883)

“…<p>Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP₂ antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Significantly activated/inactivated canonical pathways in the DEGs induced by iso-α-acids intake. by Takahito Takase (10104912)

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

Cephalometric measurement points. by Lijuan Liu (136685)